This inventor holds 3 USPTO granted patents and 3 published patent applications. Top assignee: Glaxosmithkline Biologicals Sa. Active years: 2016-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016-2019
Title: Stéphane André Georges Godart: Innovator in Immunogenic Compositions
Introduction
Stéphane André Georges Godart is a notable inventor based in Rixensart, Belgium. He has made significant contributions to the field of immunology, particularly through his innovative work on antigenic compositions. With a total of 3 patents to his name, Godart's research has the potential to impact medical practices significantly.
Latest Patents
Among his latest patents, Godart has developed immunogenic compositions that comprise an M72 related antigen. These compositions are characterized by a conductivity of 13 mS/cm or lower, or a concentration of salts of 130 mM or lower. The applications of these compositions in medicine are particularly noteworthy, as they offer new avenues for treatment and prevention.
Career Highlights
Godart is currently associated with GlaxoSmithKline Biologicals SA, where he continues to advance his research in immunogenic compositions. His work is pivotal in the development of new medical therapies that could enhance patient outcomes.
Collaborations
Throughout his career, Godart has collaborated with esteemed colleagues, including Amina Laanan and Dominique Ingrid Lemoine. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Stéphane André Georges Godart's contributions to immunology through his patents and collaborations highlight his role as a leading inventor in the field. His work continues to pave the way for advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile